⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2807684 | 0.79 | — | — | |
| SCHEMBL508798 | 0.70 | — | — | |
| SCHEMBL6561040 | 0.69 | — | — | |
| Butane SCHEMBL16500599 | 0.67 | — | — | |
| SCHEMBL508125 | 0.65 | — | — | |
| Hexadecane SCHEMBL12473013 | 0.64 | — | — | |
| SCHEMBL31135792 | 0.64 | — | — | |
| SCHEMBL31135791 | 0.64 | — | — | |
| Decane SCHEMBL29555442 | 0.64 | — | — | |
| Pentane SCHEMBL7259903 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462405-B | Preparation method and application of deuterium-labeled sphingosine compound and deuterium-labeled ceramide compound | 天津阿尔塔科技有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119462354-B | Alkyl chain end deuterium labeled fatty aldehyde compound and preparation method and application thereof | 天津阿尔塔科技有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119462405-A | Preparation method and application of deuterium-labeled sphingosine compound and deuterium-labeled ceramide compound | 天津阿尔塔科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462354-A | Alkyl chain end deuterium labeled fatty aldehyde compound and preparation method and application thereof | 天津阿尔塔科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-10799492-B2 | Deuterated analogs of pridopidine useful as dopaminergic stabilizers | PRILENIA NEUROTHERAPEUTICS LTD. (IL) | 2020-10-13 | — | — | US | disclosed |
| US-20190015401-A1 | DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2019-01-17 | — | — | US | disclosed |
| US-20180235950-A1 | DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2018-08-23 | — | — | US | disclosed |
| US-20160166559-A1 | DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2016-06-16 | — | — | US | disclosed |
| US-20160095847-A1 | DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2016-04-07 | — | — | US | disclosed |
| US-20130197031-A1 | DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS | IVAX International GmbH (CH) | 2013-08-01 | — | — | US | disclosed |
| EP-2611759-A1 | DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS | IVAX INTERNATIONAL GMBH (CH) | 2013-07-10 | — | — | EP | disclosed |
| EP-2367786-B1 | NOVEL 1 -ALKYL- 3 -HYDROXY- 3 -PHENYLAZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | NSAB AF NEUROSEARCH SWEDEN AB (DK) | 2013-01-09 | — | — | EP | disclosed |
| WO-2012028635-A1 | DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS | NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) | 2012-03-08 | — | — | WO | disclosed |
| US-20110257148-A1 | NOVEL 1-ALKYL-3-HYDROXY-3-PHENYLAZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) | 2011-10-20 | — | — | US | disclosed |
| US-20110257242-A1 | 3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) | 2011-10-20 | — | — | US | disclosed |
| EP-2367788-A1 | 3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | NSAB, Filial af NeuroSearch Sweden AB, Sverige (DK) | 2011-09-28 | — | — | EP | disclosed |
| EP-2367786-A1 | NOVEL 1 -ALKYL- 3 -HYDROXY- 3 -PHENYLAZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | NSAB, Filial af NeuroSearch Sweden AB, Sverige (DK) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010058019-A1 | 3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) | 2010-05-27 | — | — | WO | disclosed |
| WO-2010058020-A1 | NOVEL 1 -ALKYL- 3 -HYDROXY- 3 -PHENYLAZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) | 2010-05-27 | — | — | WO | disclosed |
| US-20100075935-A1 | XANTHINE MODULATORS OF ADENOSINE A1 RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-03-25 | — | — | US | disclosed |